Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DreamHug Medical vs Immortals

DreamHug Medical
Graded #386

Lower grade

vs+3.8999999999999986
Immortals
Graded #284

Higher grade

The verdict

Immortals takes it — 61.8/100 to 57.9/100.

Immortals grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Immortals is a LegitScript-certified longevity telehealth platform founded by Bryan Johnson, offering compounded semaglutide (Semaglutide/Glycine/B12) and tirzepatide (Tirzepatide/Glycine/B12) as microdose…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDreamHug Medical +3
57
54
Dose & formulationEven
64
64
Clinical oversightImmortals +28
60
88
Labs & monitoringImmortals +4
50
54
FulfillmentImmortals +1
67
68
Contract termsDreamHug Medical +21
41
20
DreamHug Medical · left barImmortals · right bar

The numbers

MetricDreamHug MedicalImmortals
WeighScore57.9/10061.8/100
GradeCC
Scorecard rank#386#284
Semaglutide$188/mo (starting dose, compounded)$167/mo (microdose tier, compounded)
Tirzepatide$238/mo (starting dose, compounded)$180/mo (microdose tier, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
DreamHug Medical

Graded #386 · C

Strengths

  • Florida business address disclosed publicly (Pompano Beach, FL) — more transparency than many DTC competitors
  • 100% money-back guarantee if you're not approved
  • Telehealth-only with claimed all-50-state coverage via an 11,000-doctor network
  • LegitScript logo displayed

Where it loses points

  • Tirzepatide not mentioned — semaglutide-only, narrower scope than competitors
  • Pricing not disclosed — fully gated behind sign-up
  • LegitScript ID number not shown (only the logo)
  • Pharmacy partner not disclosed
  • Named medical director not disclosed
Immortals

Graded #284 · C

Strengths

  • LegitScript certified (ID 50458743) with board-certified U.S. physician review within 72 hours
  • Physician consult + prescription bundled in price — 'You pay for treatment. That's it' with no added fees
  • Competitive pricing: semaglutide microdose from $167/month, tirzepatide from $180/month (promotional)
  • Unlimited provider messaging for 12 months included; video consults available
  • Founded by Bryan Johnson and Kate Tolo; clinical lead Dr. Carl Seger, M.D. (preventive/longevity medicine)

Where it loses points

  • Microdose framing uses sub-clinical doses — lower weight-loss efficacy than standard GLP-1 protocols
  • Quarterly commitment only — 3-month minimum, paid upfront ($501–$540/quarter); no monthly flexibility
  • State availability not publicly listed; 'eligible U.S. states' with no specific state list
  • Labs not included; baseline bloodwork protocol not disclosed on any public page
  • Compounding pharmacy not named; no 503A/503B accreditation details disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard